EGFR and neoplasm: Interestingly, TDEs in oral cancer can also transfer oncogenic EGFR from tumor cells to endothelial cells, thus increasing the expression of vascular endothelial growth factor (VEGF); this can support invasiveness and metastasis, thus promoting neovascularization and tumor niche formation [148].